Technology

89bio, Inc

$21.11
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.22 (+1.05%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell 89bio, Inc and other stocks, options, and ETFs commission-free!

About ETNB

89bio, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases. The company was founded on January 01, 2018 and is headquartered in San Francisco, CA. The listed name for ETNB is 89bio, Inc. Common Stock.

CEO
Rohan Palekar
Employees
20
Headquarters
San Francisco, California
Founded
2018
Market Cap
419.64M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
334.83K
High Today
$21.24
Low Today
$20.73
Open Price
$21.00
Volume
216.98K
52 Week High
$47.25
52 Week Low
$14.00

Collections

ETNB Earnings

-$30.63
-$20.42
-$10.21
-$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 17, After Hours

You May Also Like

EFAX
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure